RDX-002(Response Pharmaceuticals)

N/A

Report date: 2025/08/18 13:44:20
NME

Base Information

Drug NameRDX-002(Response Pharmaceuticals)
Drug Alias NameRDX-002(Response Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrosomal triglyceride transfer protein inhibitors
TargetsMicrosomal triglyceride transfer protein
Therapy Area/IndicationsWeight Gain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesResponse Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesResponse Pharmaceuticals IncResponse Pharma Pvt Ltd
Inactive CompaniesN/A
Active IndicationsWeight Gain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A